Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AFC Agro Biotech's enterprise value is BDT1,791.4 Mil.
AFC Agro Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was BDT36.5 Mil. Therefore, AFC Agro Biotech's EV-to-EBITDA for today is 49.10.
The historical rank and industry rank for AFC Agro Biotech's EV-to-EBITDA or its related term are showing as below:
DHA:AFCAGRO's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13.48 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
AFC Agro Biotech (DHA:AFCAGRO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AFC Agro Biotech's PE Ratio (TTM) for today is calculated as:
AFC Agro Biotech's share price for today is BDT6.70.
AFC Agro Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for AFC Agro Biotech's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:AFCAGRO vs ZTS, VTRS, NBIX: EV-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFC Agro Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFC Agro Biotech EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFC Agro Biotech's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where AFC Agro Biotech's EV-to-EBITDA falls into.
AFC Agro Biotech's current Enterprise Value is BDT1,791.4 Mil.
AFC Agro Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT36.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFC Agro Biotech (DHA:AFCAGRO) has a EV-to-EBITDA of 49.10 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on AFC Agro Biotech.
Is AFC Agro Biotech's EV-to-EBITDA too high?
AFC Agro Biotech's current EV-to-EBITDA is 49.10. The Drug Manufacturers industry median EV-to-EBITDA is 13.48. AFC Agro Biotech's value of 49.10 is 264.2% above this industry median. Overall, AFC Agro Biotech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does AFC Agro Biotech's EV-to-EBITDA compare to ZTS and VTRS?
AFC Agro Biotech's EV-to-EBITDA of 49.10 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBITDA is 13.48. AFC Agro Biotech's value of 49.10 is 264.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.48, based on 729 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AFC Agro Biotech's current EV-to-EBITDA of 49.10 is 264.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on AFC Agro Biotech. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFC Agro Biotech's current EV-to-EBITDA is 49.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFC Agro Biotech stock overvalued right now?
AFC Agro Biotech (DHA:AFCAGRO) has a current EV-to-EBITDA of 49.10. The current EV-to-EBITDA is 49.10 and 264.2% above the Drug Manufacturers industry median of 13.48. AFC Agro Biotech's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For AFC Agro Biotech (DHA:AFCAGRO), the current EV-to-EBITDA is 49.10 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AFC Agro Biotech Ltd is a biotech products manufacturer. It is engaged in manufacturing biopharmaceuticals and biochemicals. It manufactures antibiotics, proteins, vaccines, enzymes from agricultural ingredients like molasses, glucose, potato starch, and other nutrients. The products manufactured by the company are macrolide protein, acetic acid, L-Lysine, monosodium glutamate, methionine, calcium hydrogen orthophosphate, magnesium carbonate, and sodium carbonate. It sells its products to the local markets in Bangladesh.
10GF Score
Get the complete analysis for DHA:AFCAGRO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:AFCAGRO has been successfully added to your 
